| 產(chǎn)品詳情 |
| Edit |   |
|---|
| Product Name | Gemcitabine Hydrochloride |
|---|
| Description | A nucleoside analog of deoxycytidine used in chemotherapy to treat various types of cancer. Gemcitabine is converted intracellularly to the active metabolites difluorodeoxycytidine di- and triphosphate (dFdCDP, dFdCTP). dFdCDP inhibits ribonucleotide reductase, thereby decreasing the deoxynucleotide pool available for DNA synthesis; dFdCTP is incorporated into DNA, resulting in DNA strand termination and apoptosis. MW: 299.66. Purity ≥98% by HPLC |
|---|
| Size | 100 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | 2?,2?-difluoro-2?-deoxycytidine; Gamcitabine; Gemcitera; Gemsar; Gemzar; LY-188012 |
|---|
| Gene, Accession, CAS # | CAS: 122111-03-9 |
|---|
| Catalog # | 1759-100 |
|---|
| Price | |
|---|
| Order / More Info | Gemcitabine Hydrochloride from BIOVISION, INC. |
|---|
| Product Specific References | n/a |
|---|
| 產(chǎn)品資料 |
|
|